Should We Start Using OCT in Myocardial Infarction with Non-Obstructive Lesions?

In ST elevation MI, the common assessment methodology continues to the angiography; however, we all know it has certain limitations, especially when it comes to intermediate lesions or coronary dissections.  

¿Debemos comenzar a usar OCT en los IAM sin lesiones obstructivas?

Using imaging, especially high resolution such as OCT, has been looked into by some studies, but never randomized studies. 

The EROSION III is a randomized controlled study on patients with ST elevation MI who after guidewire lesion crossing should present a non-obstructive lesion (≤70%) and TIMI flow III. Predilation was excluded, but thrombus aspiration was allowed, when necessary. 

The study looked at 226 patients, 112 guided by OCT and 114 by angiography.

There were no differences between populations: mean age was 55, 80% were men, 21% were diabetic. Thrombus aspiration was done in 93% of patients and obstruction rate was 54%.

Read also: Is Increased Mitral Valve Gradient After MitraClip a Long-Term Prognostic Factor?

OCT patients saw 66% plaque rupture, 26% plaque erosion, 4.5% calcified nodules, 0.9% intimal fissure and 2.7% no evidence of obstruction or atherosclerotic lesion. 

Anterior descending infarction was more frequent in the OCT group. Also, this population presented longer procedural time.  

The OCT group saw 15% reduction in stent implantation (43.8% vs 53.8% p=0.024) and residual lesions (4.6% vs 8.7% p<0.001).

Read also: Hypertrophic Cardiomyopathy: Analyzing a Historical Series.

After one year, there were no differences in death, stroke, MI, TLR, malign arrythmia, rehospitalization for unstable angina or cardiac failure. 

Conclusion

In patients with ST elevation MI, OCT guided reperfusión compared against angiography guided reperfusión was associated with lower stent implantation rate at primary PCI. These favorable results indicate the value of OCT imaging guided reperfusión in patients with ST elevation MI. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board in SOLACI.org .

Original Title: EROSION III A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency.

Reference: Haibo Jia, et al. J Am Coll Cardiol Intv 2022;15:846–856.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...